Literature DB >> 18292718

Postoperative mortality in lung cancer patients.

Kanji Nagai1, Junji Yoshida, Mitsuyo Nishimura.   

Abstract

Surgery for lung cancer frequently results in serious life-threatening complications, and the surgery itself may become the cause of death. Mortality within 30 days following lung cancer surgery ranges of 0.6-5.2%, as reported from a study of a great many patients (more than 1,000). Surgical mortality is high among elderly patients and those suffering from compromised respiratory functions. When stratified by surgical procedures, mortality was high after pneumonectomy or, in particular, after pneumonectomy of the right lung. Surgical mortality was also higher in hospitals where the number of lung cancer surgeries was limited, compared to those where many cases are normally handled. Surgical mortality involving lung cancer patients was lower in reports from Japan in comparison with those from the Western world. According to a report by the Japanese Joint Committee of Lung Cancer Registry, the 30-day mortality of lung cancer surgery is 1.4%, and in-hospital mortality is 1.7%.

Entities:  

Mesh:

Year:  2007        PMID: 18292718

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  3 in total

1.  The 30-day mortality and hospital mortality after chest surgery described in the annual reports published by the Japanese Association for Thoracic and Cardiovascular Surgery.

Authors:  Hidetaka Uramoto; Meinoshin Okumura; Shunsuke Endo; Fumihiro Tanaka; Hiroyasu Yokomise; Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-02-06

2.  A new scoring system for predicting in-hospital death after lung cancer surgery (the SABCIP score) using a Japanese nationwide administrative database.

Authors:  Masahiro Tahara; Tomohiro Ishimaru; Yoshihisa Fujino; Kiyohide Fushimi; Shinya Matsuda; Hiroshi Mukae; Kazuhiro Yatera
Journal:  Thorac Cancer       Date:  2022-02-06       Impact factor: 3.500

3.  Comorbidity and survival of Danish lung cancer patients from 2000-2011: a population-based cohort study.

Authors:  Thomas Deleuran; Reimar Wernich Thomsen; Mette Nørgaard; Jacob Bonde Jacobsen; Torben Riis Rasmussen; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2013-11-01       Impact factor: 4.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.